103285-22-9
103285-22-9 structure
- Name: 2'-O-Methyl-5'-O-DMT-Uridine;DMT-2'-OMe-U
- Chemical Name: 1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione
- CAS Number: 103285-22-9
- Molecular Formula: C31H32N2O8
- Molecular Weight: 560.59
- Catalog: Biochemical Nucleoside drugs Nucleoside intermediate
- Create Date: 2018-12-01 10:39:50
- Modify Date: 2026-07-01 08:13:36
-
5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1].
| Name | 1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione |
|---|---|
| Synonyms |
oligoadenylate Synthetase 1, 40/46kD, IFI-4, OIAS, OIASI) (Biotin)
HG1364 5'-O-DMT-2'-O-METHYL-URIDINE cyclic Phosphodiesterase B, Cyclic GMP-inhibited Phosphodiesterase B, HcGIP1) nucleotidase, Thiamine Monophosphatase, TMPase) (PE) 5'-DMT 2'-O-methyl uridine cyclic Monophosphate) (HPLC) cyclic phosphodiesterase 4C, PDE21) deoxyinosine (HPLC) Dibromoacetophenone &ge P1,P3-triphosphate hydrolase, Dinucleosidetriphosphatase, Tumor Suppressor Protein, AP3Aase, FRA3B) nucleotidase 1, PAP-inositol 1,4-phosphatase, PIP) 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-uridine 8-d3 dimethoxytrityl) thymidine (synthetic) (TLC) cyclic phosphodiesterase 4B, DPDE4, PDE32) (APC) cyclic phosphodiesterase 8B, Cell proliferation-inducing gene 22 protein) NT, eN, eNT, NT5, NT5E, NTE, Purine 5 Prime Nucleotidase) Cyclic-AMP and -GMP Phosphodiesterase 11A, cAMP and cGMP Phosphodiesterase 11A) 5'-O-(DIMETHOXYTRITYL)-2'-O-METHYLURIDINE trifluoroacetamidocytidine cyclic nucleotide phosphodiesterase 1B, PDE1B1, PDES1B) P1,P6-hexaphosphate Hydrolase 1, Nucleoside Diphosphate-linked Moiety X Motif 3, Nudix Motif 3, DIPP, DIPP1) 5'-O-(4,4'-DIMETHOXYTRITYL)-2'-O-METHYLURIDINE DMT-2'-OMe-U DMT-2'-O-METHYLURIDINE anhydrouridine cyclic Phosphodiesterase Subunit Alpha, Phosphodiesterase 6C, cGMP-specific, Cone, Alpha Prime) 2'-O-methyl-5"-O-dimethoxytrityl uridine Nucleotidase, Cytosolic III (NT5C3) PDE10A, BioAssay&trade 1-((2R,3R,4R,5R)-5-((bis(4-Methoxyphenyl)(phenyl)Methoxy)Methyl)-4-hydroxy-3-Methoxytetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione oligoadenylate Synthase-like Protein, p59 OASL, p59OASL, Thyroid Rector-interacting Protein 14, TR-interacting Protein 14, TRIP-14, TRIP14) pyrophosphohydrolase, (ppGpp)ase, MESH1) cyclic Phosphodiesterase 9A, FLJ90181, HSPDE9A2) PDE3B, BioAssay&trade 5'-O-DMT-2'-O-methyluridine Exonuclease TREX1, AGS1, CRV, DNase III, DRN3, HERNS) bisphosphate, Triethylammonium Salt (Biotin) cyclic phosphodiesterase subunit delta, Protein p17) P1,P4-tetraphosphate asymmetrical hydrolase, Nucleoside diphosphate-linked moiety X motif 2) cyclic Phosphodiesterase B, CGIPDE1, CGIP1, Cyclic GMP-inhibited Phosphodiesterase B, CGI-PDE B) Methoxylaudanosine dimethoxybenzyloxy)phenylboronic acid Uridine, 5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-O-Methyl 5'-O-DMT-2'-O-methyl-D-uridine deoxy-b-D-ribofuranosyl]guanine terthiophene]-5-cbaldehyde cyclic Phosphodiesterase 10A) nucleotidase 1, PIP, PAP-inositol-1,4-phosphatase, HEL20) bisphosphate nucleotidase 1, PIP) nucleotidase 1, PAP-inositol 1,4-phosphatase) Bis-(S)-phosphate cyclic Nucleotide Phosphodiesterase 1A, Cam-PDE 1A, 61kD Cam-PDE, hCam-1, M26303) (FITC) cyclic Phosphodiesterase A, Cyclic GMP-inhibited Phosphodiesterase A, CGI-PDE A) (FITC) deoxyadenosine &ge tri-O-tert-butyldimethylsilyl-b-D-ribofuranosyl)-imidazo[4,5-c]pyridine oligoadenylate synthase 1, E18/E16, p46/p42 OAS) d4 3-O-&beta cyclic phosphodiesterase 4C, PDE21) (PE) cyclic Phosphodiesterase 10A, FLJ11894, FLJ25677, HSPDE10A) (PE) )oligo(A) Synthase 3, A Synthase 3, p100 OAS, p100OAS, P/OKcl.4) (FITC) di-O-tritylguanosine |
| Description | 5’-O-(4,4’-Dimethoxytrityl)-2’-O-methyluridine is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C31H32N2O8 |
|---|---|
| Molecular Weight | 560.59 |
| Exact Mass | 560.21600 |
| PSA | 121.24000 |
| LogP | 2.83580 |
| Appearance | Powder | White to Pale Yellow |
| Storage condition | Store dry at 2-8°C |
|
~65%
103285-22-9 |
| Literature: Buettner, Lea; Seikowski, Jan; Wawrzyniak, Katarzyna; Ochmann, Anne; Hoebartner, Claudia Bioorganic and Medicinal Chemistry, 2013 , vol. 21, # 20 p. 6171 - 6180 |
|
~99%
103285-22-9 |
| Literature: ISIS Pharmaceuticals, Inc. Patent: US5914396 A1, 1999 ; |
|
~90%
103285-22-9 |
| Literature: Barbeyron, Renaud; Wengel, Jesper; Vasseur, Jean-Jacques; Smietana, Michael Monatshefte fur Chemie, 2013 , vol. 144, # 4 p. 495 - 500 |
|
~%
103285-22-9 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 21, # 20 p. 6171 - 6180 |
|
~%
103285-22-9 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 21, # 20 p. 6171 - 6180 |
